In summary, we developed a new DNA vaccine (YM3711, IgL-Aβx4-Fc-IL-4) and found that it induced antibodies against a wide variety of Aβ species and other amyloidogenic peptides, resulting in significant reduction of these molecules in the brain of AD model mice. Here, IL4 is linked to Alzheimer disease.